OtherInvited Perspectives
Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies
Harm Westdorp, Sarah R. Verhoeff, Martin Gotthardt, Carla M.L. van Herpen, Michel M. van den Heuvel, Sandra Heskamp and Erik H.J.G. Aarntzen
Journal of Nuclear Medicine January 2022, jnumed.121.262622; DOI: https://doi.org/10.2967/jnumed.121.262622
Harm Westdorp
1 Department of Medical Imaging, Radboudumc, Netherlands;
Sarah R. Verhoeff
1 Department of Medical Imaging, Radboudumc, Netherlands;
Martin Gotthardt
1 Department of Medical Imaging, Radboudumc, Netherlands;
Carla M.L. van Herpen
2 Department of Medical Oncology, Radboudumc, Netherlands;
Michel M. van den Heuvel
3 Department of Pulmonary diseases, Radboudumc, Netherlands
Sandra Heskamp
1 Department of Medical Imaging, Radboudumc, Netherlands;
Erik H.J.G. Aarntzen
1 Department of Medical Imaging, Radboudumc, Netherlands;


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 4
April 1, 2025
Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies
Harm Westdorp, Sarah R. Verhoeff, Martin Gotthardt, Carla M.L. van Herpen, Michel M. van den Heuvel, Sandra Heskamp, Erik H.J.G. Aarntzen
Journal of Nuclear Medicine Jan 2022, jnumed.121.262622; DOI: 10.2967/jnumed.121.262622
Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies
Harm Westdorp, Sarah R. Verhoeff, Martin Gotthardt, Carla M.L. van Herpen, Michel M. van den Heuvel, Sandra Heskamp, Erik H.J.G. Aarntzen
Journal of Nuclear Medicine Jan 2022, jnumed.121.262622; DOI: 10.2967/jnumed.121.262622
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.